Filing Details
- Accession Number:
- 0001203311-20-000120
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-11-04 20:51:39
- Reporting Period:
- 2020-11-02
- Accepted Time:
- 2020-11-04 20:51:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1060736 | Seagen Inc. | SGEN | Biological Products, (No Disgnostic Substances) (2836) | 911874389 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1206199 | G Daniel Welch | 21823 30Th Drive Se Bothell WA 98021 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-11-02 | 8,750 | $34.25 | 65,348 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-11-02 | 8,750 | $168.24 | 56,598 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-11-02 | 8,750 | $36.70 | 65,348 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-11-02 | 8,750 | $167.34 | 56,598 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-11-02 | 7,982 | $20.06 | 64,580 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-11-02 | 7,982 | $166.70 | 56,598 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-11-02 | 9,518 | $20.06 | 66,116 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-11-02 | 9,518 | $165.72 | 56,598 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-11-02 | 14,500 | $19.02 | 71,098 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-11-02 | 14,500 | $165.06 | 56,598 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-11-02 | 9,250 | $164.61 | 47,348 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-11-02 | 14,500 | $0.00 | 14,500 | $19.02 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-11-02 | 7,982 | $0.00 | 7,982 | $20.06 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-11-02 | 9,518 | $0.00 | 9,518 | $20.06 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-11-02 | 8,750 | $0.00 | 8,750 | $34.25 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-11-02 | 8,750 | $0.00 | 8,750 | $36.70 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2021-05-19 | No | 4 | M | Direct | |
| 9,518 | 2022-05-17 | No | 4 | M | Direct | |
| 0 | 2022-05-17 | No | 4 | M | Direct | |
| 0 | 2024-05-15 | No | 4 | M | Direct | |
| 0 | 2023-05-17 | No | 4 | M | Direct |
Footnotes
- Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $167.91 to $168.77. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $166.98 to $167.91. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $166.33 to $166.98. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $165.31 to $166.30. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $164.72 to $165.31. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $164.49 to $164.72. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Options were fully vested on 5/20/12.
- Options were fully vested on 5/17/13.
- Options were fully vested on 5/15/15.
- Options were fully vested on 5/16/14.
Billionaire Hedge Funds
